06.14.2022 Kabuki Syndrome Foundation Awards $125,000 to Fund Research at Kennedy Krieger Institute BALTIMORE, June 14, 2022—Dr. Jacqueline Harris, a pediatric neurologist and director of Kennedy Krieger’s Epigenetics...
05.03.2022 ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, May 3rd, 2022 – Oryzon Genomics, S.A. (ISIN Code:...
02.28.2022 Kennedy Krieger Patient with Kabuki Syndrome Stars in Episode of ABC’s ‘The Good Doctor,’ Spotlighting This Rare Disease BALTIMORE, February 28, 2022 – A Kennedy Krieger Institute physician and a longtime patient play important roles in an...
09.21.2021 Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with Vafidemstat HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases...